(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PKANALIX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

PKANALIX

ST13

US500000079263378

Class

9, 42

Filing

79263378

Registration

6010417

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

06/02/2026

Trademark type

Combined

Nice classes

9, 42

Filing date

04/26/2019

Registration date

03/17/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/17/2020

Last transaction

06/02/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

98

Owner location

FR

Examiner

MCDOWELL, MATTHEW J

Law office

L10

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "PKanalix" in a stylized font.

Holders and representatives

Holders

S. F. (pessoa física)
LIXOFT

Representatives

Cathleen E. Stadecker Downs Rachlin Martin PLLC

Technical classification

Nice Classes

Class 9Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Electric and electronic apparatus and instrumentscomputer hardware and recorded software sold as a unit for the measuringstorageencodingmemorizingindicatinganalysisprocessingproduction and transmission of data and signals; digital simulation devices and instrumentsmedical simulators for use in the process of clinical trialsof pre-clinical trialsof drug development and of individualized optimization of therapeutic treatments; devices and instruments for graphics and statistical analysiscomputers; apparatus for the recordingtransmission or reproduction of data; signal receiving terminalsreceivers of electronic signals; blank magnetic data carriersblank recordable optical discs for sound recording; data processing equipment and computers; integrated circuit cardsblank smart cards; computers and computer peripherals; computer parts and components for visual and graphic data and information processingdevelopment and displaycomputer peripheral devices; recorded downloadable computer software for population analysis in pre-clinical and clinical trialsfor customized optimization of therapeutic treatmentsfor mathematical modelling and simulationfor reporting the concentration of drugs in patients during a treatment and for statistical and data analysis; recorded downloadable computer software for pharmacokinetic data analysis; recorded downloadable computer software for use for controlling and managing patient medical informationdrug efficiency and drug concentration in patients during a treatment for medical use; recorded downloadable computer software used to process and interpret diagnostic test results; recorded downloadable computer software for collectingstoring and processing dataimagesphotographsaudiovisual and audio-visual data; recorded downloadable database management software; recorded computer software for database server centers; computer apparatuscomputers and computer peripherals for providing access to data banks; downloadable recorded computer software for accessingbrowsing and searching online databases

Class 42

Evaluationsassessments and research in the scientifictechnological and medical fields provided by engineersengineering services; Engineering services involving evaluationsestimatesresearch and reporting in scientifictechnological and medical fields; medical and scientific research in the field of pharmacokinetic data analysis; laboratory services for scientific and medical research; conducting clinical trials for others; research and development of new products for third parties; technical project studiesdrug and medical devices discovery servicesdesign and development of drugsmodelingsimulationstatistics and data analysis; design and development of computers and software; research in the field of software; developmentdesigninstallationmaintenanceupdating and rental of software; computer programming; providing information with respect to medical research; assistance in the nature of advice and consulting in connection with the development of systemsdatabases and computer applications; conversion of computer programs and dataother than physical conversion; informationadvicesupport services in the nature of troubleshooting of computer software problems relating to any of the aforementioned services

Publications

History of USPTO decisions and trademark events.

36 publications found

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/01/2026

ES75

TEAS SECTION 71 & 15 RECEIVED

02/11/2026

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

04/25/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

03/17/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/20/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/29/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/14/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/28/2020

FIMP

FINAL DISPOSITION PROCESSED

07/28/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/17/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

03/17/2020

GPNX

NOTIFICATION PROCESSED BY IB

01/04/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/31/2019

PUBO

PUBLISHED FOR OPPOSITION

12/31/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/18/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

12/18/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/11/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/22/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/08/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/18/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/17/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/17/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/03/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/03/2019

RFNT

REFUSAL PROCESSED BY IB

09/20/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/05/2019

RFRR

REFUSAL PROCESSED BY MPU

09/04/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/16/2019

CNRT

NON-FINAL ACTION WRITTEN

08/15/2019

RFWR

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

08/12/2019

MAFR

APPLICATION FILING RECEIPT MAILED

07/24/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

07/21/2019

CNRT

NON-FINAL ACTION WRITTEN

07/20/2019

DOCK

ASSIGNED TO EXAMINER

07/20/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/20/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/18/2019

Continuous trademark protection

Get notified about every new filing that threatens PKANALIX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.